Perez EA - Search Results

1

Issues and controversies in the treatment of HER2 positive metastatic breast cancer.

Amar S, Moreno-Aspitia A, Perez EA. Amar S, et al. Among authors: perez ea. Breast Cancer Res Treat. 2008 May;109(1):1-7. doi: 10.1007/s10549-007-9636-2. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653858 Review.

2

HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization.

Perez EA, Roche PC, Jenkins RB, Reynolds CA, Halling KC, Ingle JN, Wold LE. Perez EA, et al. Mayo Clin Proc. 2002 Feb;77(2):148-54. doi: 10.4065/77.2.148. Mayo Clin Proc. 2002. PMID: 11838648

3

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831.

Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA, Addo FK, Murphy B, Ingle JN, Perez EA. Roche PC, et al. Among authors: perez ea. J Natl Cancer Inst. 2002 Jun 5;94(11):855-7. doi: 10.1093/jnci/94.11.855. J Natl Cancer Inst. 2002. PMID: 12048274

4

Adjuvant therapy for breast cancer: recommendations for management based on consensus review and recent clinical trials.

Mincey BA, Palmieri FM, Perez EA. Mincey BA, et al. Among authors: perez ea. Oncologist. 2002;7(3):246-50. doi: 10.1634/theoncologist.7-3-246. Oncologist. 2002. PMID: 12065798 Free article. Review.

5

Adjuvant therapy approaches to breast cancer: should taxanes be incorporated?

Perez EA. Perez EA. Curr Oncol Rep. 2003 Jan;5(1):66-71. doi: 10.1007/s11912-003-0089-4. Curr Oncol Rep. 2003. PMID: 12493153 Review.

6

Recent advances in adjuvant therapy for breast cancer.

Palmieri FM, Perez EA. Palmieri FM, et al. Among authors: perez ea. Semin Oncol Nurs. 2003 Nov;19(4 Suppl 2):10-6. doi: 10.1053/j.soncn.2003.09.004. Semin Oncol Nurs. 2003. PMID: 14702916 Review.

7

Clinical cardiac tolerability of trastuzumab.

Perez EA, Rodeheffer R. Perez EA, et al. J Clin Oncol. 2004 Jan 15;22(2):322-9. doi: 10.1200/JCO.2004.01.120. J Clin Oncol. 2004. PMID: 14722042 Review.

8

Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanes.

Perez EA. Perez EA. Clin Breast Cancer. 2004 Jan;4 Suppl 3:S113-6. doi: 10.3816/cbc.2004.s.004. Clin Breast Cancer. 2004. PMID: 14754468 Review.

9

Advances in screening, diagnosis, and treatment of breast cancer.

Mincey BA, Perez EA. Mincey BA, et al. Among authors: perez ea. Mayo Clin Proc. 2004 Jun;79(6):810-6. doi: 10.4065/79.6.810. Mayo Clin Proc. 2004. PMID: 15182098 Review.

10

Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.

Perez EA, Hillman DW, Mailliard JA, Ingle JN, Ryan JM, Fitch TR, Rowland KM, Kardinal CG, Krook JE, Kugler JW, Dakhil SR. Perez EA, et al. J Clin Oncol. 2004 Jul 15;22(14):2849-55. doi: 10.1200/JCO.2004.10.047. J Clin Oncol. 2004. PMID: 15254052 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

627 results

Search Page

Filters